Technical Analysis for MRNA - Moderna, Inc.

Grade Last Price % Change Price Change
A 348.83 7.84% 25.35
MRNA closed up 7.84 percent on Friday, July 23, 2021, on 1.93 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Aug 3
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical MRNA trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
New 52 Week High Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
New 52 Week Closing High Bullish 7.84%
Calm After Storm Range Contraction 7.84%
Older End-of-Day Signals for MRNA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Life Sciences Biology Nasdaq 100 Coronavirus Vaccine RNA Cancer Vaccine Cancer Vaccines Messenger RNA

Is MRNA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 349.41
52 Week Low 54.21
Average Volume 12,129,047
200-Day Moving Average 152.81
50-Day Moving Average 218.16
20-Day Moving Average 259.21
10-Day Moving Average 288.16
Average True Range 18.56
ADX 42.14
+DI 45.68
-DI 5.67
Chandelier Exit (Long, 3 ATRs) 293.73
Chandelier Exit (Short, 3 ATRs) 261.23
Upper Bollinger Bands 339.03
Lower Bollinger Band 179.39
Percent B (%b) 1.06
BandWidth 61.59
MACD Line 31.51
MACD Signal Line 22.25
MACD Histogram 9.2622
Fundamentals Value
Market Cap 138.04 Billion
Num Shares 396 Million
EPS -2.35
Price-to-Earnings (P/E) Ratio -148.56
Price-to-Sales 233.14
Price-to-Book 22.55
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 385.19
Resistance 3 (R3) 381.34 365.38 379.13
Resistance 2 (R2) 365.38 356.12 367.30 377.11
Resistance 1 (R1) 357.10 350.40 361.24 360.95 375.09
Pivot Point 341.14 341.14 343.21 343.06 341.14
Support 1 (S1) 332.86 331.88 337.00 336.71 322.57
Support 2 (S2) 316.90 326.16 318.82 320.55
Support 3 (S3) 308.62 316.90 318.53
Support 4 (S4) 312.47